Phospho-p70s6k and cdc2/cdk1 Are Associated with Diffuse Large B-Cell Lymphoma and Are Potential Targets for Combination

被引：0
|
作者：
Zhao, M. Y.
Auerbach, A.
Costa, A. D.
Rapoport, A. P.
Burger, A. M.
Jiang, F.
Stass, S. A.
Sands, A. K.
Aguilera, N.
Sausville, E. A.
Zhao, X. F.
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Armed Forces Inst Pathol, Washington, DC 20306 USA
[3] Univ Maryland Marlene, Baltimore, MD USA
[4] Stewart Greenebaum Canc Ctr, Baltimore, MD USA
[5] SUNY Buffalo, Buffalo, NY 14260 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1325
引用
收藏
页码：293A / 293A
页数：1
相关论文
共 50 条
  • [1] Phospho-p70s6k and cdc2/cdk1 Are Associated with Diffuse Large B-Cell Lymphoma and Are Potential Targets for Combination Chemotherapy
    Zhao, M. Y.
    Auerbach, A.
    DCosta, A.
    Rapoport, A. P.
    Burger, A. M.
    Jiang, F.
    Stass, S. A.
    Sands, A. K.
    Aguilera, N.
    Sausville, E. A.
    Zhao, X. F.
    MODERN PATHOLOGY, 2009, 22 : 293A - 293A
  • [2] Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma
    Zhao, Xianfeng Frank
    Gartenhaus, Ronald B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (09) : 1085 - 1093
  • [3] Phospho-p70S6K/p85S6K and cdc2/cdk1 Are Novel Targets for Diffuse Large B-Cell Lymphoma Combination Therapy
    Zhao, Merry Y.
    Auerbach, Aaron
    D'Costa, Anisha M.
    Rapoport, Aaron P.
    Burger, Angelika M.
    Sausville, Edward A.
    Stass, Sanford A.
    Jiang, Feng
    Sands, Amy M.
    Aguilera, Nadine
    Zhao, X. Frank
    CLINICAL CANCER RESEARCH, 2009, 15 (05) : 1708 - 1720
  • [4] Prognostic significance of CDK1 expression in diffuse large B-Cell lymphoma
    Chen, Qiuni
    Xu, Lei
    Lu, Chuanyang
    Xue, Yujie
    Gong, Xue
    Shi, Yuye
    Wang, Chunling
    Yu, Liang
    BMC CANCER, 2025, 25 (01)
  • [5] Amplified RPS6KB1 and CDC2 genes are potential biomarkers for aggressive HIV+/EBV+ diffuse large B-cell lymphomas
    Zhao, Xianfeng F.
    Zhao, Merry Y.
    Chai, Ling
    Kukuruga, Debra
    Tan, Ming
    Stass, Sanford A.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (02): : 148 - 154
  • [6] Amplified RPS6KB1 and CDC2 Are Potential Biomarkers for Aggressive Large B-Cell Lymphomas in HIV Patients
    Zhao, X. F.
    Zhao, M. Y.
    Cai, L.
    Kukuruga, D.
    Tan, M.
    Stass, S. A.
    MODERN PATHOLOGY, 2012, 25 : 384A - 384A
  • [7] Amplified RPS6KB1 and CDC2 Are Potential Biomarkers for Aggressive Large B-Cell Lymphomas in HIV Patients
    Zhao, X. F.
    Zhao, M. Y.
    Cai, L.
    Kukuraga, D.
    Tan, M.
    Stass, S. A.
    LABORATORY INVESTIGATION, 2012, 92 : 384A - 384A
  • [8] CDK1 inhibitor RO-3306 enhances BTKi potency in diffuse large B-cell lymphoma by suppressing JAK2/STAT3 signaling
    Chen, Qiuni
    Lu, Chuanyang
    Li, Dongnan
    Xu, Lei
    Wang, Chunling
    Yu, Liang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 297
  • [9] Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma
    Kasugai, Y
    Tagawa, H
    Kameoka, Y
    Morishima, Y
    Nakamura, S
    Seto, M
    CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8265 - 8272
  • [10] SRPK1 and SRPK2: Potential Diagnostic Marker for Diffuse Large B-Cell Lymphoma
    Minoo, P.
    Fu, X-D
    Wang, H-Y
    MODERN PATHOLOGY, 2013, 26 : 348A - 348A
12345